Ongoing Registry of Treatment of Venous Thromboembolism

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedalp Private Surgery Clinic

About this trial

Ongoing registration of patients with venous thromboembolism treated by means of antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

case of venous thrombosis of a limb or pulmonary embolus

Disqualifiers

no exclusion criteria

Trial population

Patients undergoing any kind of treatment for venous thromboembolism

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Anticoagulants

    Drug

    anticoagulation according to the main diagnosis

  • Open surgery

    Procedure/Surgery

    removal of blood clots with open surgery

  • Thrombolysis

    Procedure/Surgery

    removal of blood clots with thrombolysis

  • Venous stenting

    Procedure/Surgery

    elimination of vein obstruction by stenting

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Veins patency

Change in patency target veins assessed by duplex ultrasonography in different follow up periods due to different treatment methods

Time frame
Baseline, 3 and 12 months post-intervention

Secondary outcomes

1

Postthrombotic syndrome

the presence and severity of postthrombotic syndrome on the Villalta scale

Time frame
Baseline, 3 and 12 months post-intervention
2

QoL SF-36

Change in Quality of Life (QoL), assessed by "Short form 36" health survey (SF-36). Total scale range: from 0 to 800. SF-36 consists of 8 subscales. Each subscale range: 0 - 100. Subscales are combined using a special algorithm described in the instructions for the SF-36. For total scale the higher value represent the worse QoL.

Time frame
Baseline, 3 and 12 months post-intervention
3

QoL AVVQ

Change in Quality of Life (QoL), assessed by "Aberdeen Varicose Vein Questionnaire" (AVVQ). The AVVQ is a disease-specific QoL questionnaire aimed at venous disease. Total scale range: from 0 to 100, where the higher score represent worse QoL.

Time frame
Baseline, 3 and 12 months post-intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medalp Private Surgery Clinic

Lead sponsor

State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia

Collaborator